Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Philippe Lanoix

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Infectious Diseases Now|December 22, 2025
Knowledge of the French public on antibiotics: where do we stand, twenty years after the celebrated public health campaign "Antibiotics are not Automatic"?Jean-Philippe Lanoix
Advances in Mind-Body Medicine|January 29, 2021
Holistic Medicine Must Mean Whole: How to Deal with SpiritualityJean-Philippe Lanoix, Loren Toussaint
Jac-Antimicrobial Resistance|January 8, 2024
Successful prophylaxis of ESBL Enterobacteriaceae repetitive urinary tract infections with subcutaneous temocillin: a case reportEloïse Delpierre, Jean-Philippe Lanoix
Antimicrobial Agents and Chemotherapy|February 5, 2014
Novel regimens identified in mice for treatment of latent tuberculosis infection in contacts of patients with multidrug-resistant tuberculosisJean-Philippe Lanoix, Fabrice Betoudji, Eric Nuermberger
Antimicrobial Agents and Chemotherapy|December 9, 2015
Sterilizing Activity of Pyrazinamide in Combination with First-Line Drugs in a C3HeB/FeJ Mouse Model of TuberculosisJean-Philippe Lanoix, Fabrice Betoudji, Eric Nuermberger
Current Opinion in Pulmonary Medicine|February 21, 2012
Bacterial lung sepsis in patients with febrile neutropeniaJean-Philippe Lanoix, Jean-Luc Schmit, Youcef Douadi
Disease Models & Mechanisms|June 3, 2015
Heterogeneous disease progression and treatment response in a C3HeB/FeJ mouse model of tuberculosisJean-Philippe Lanoix, Anne J Lenaerts, Eric L Nuermberger
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 4, 2015
Shortening Tuberculosis Treatment With Fluoroquinolones: Lost in Translation?Jean-Philippe Lanoix, Richard E Chaisson, Eric L Nuermberger
Pathogens (Basel, Switzerland)|November 24, 2022
Cytomegalovirus-Associated Gianotti-Crosti Syndrome in 28-Year-Old Immunocompetent PatientFlorence Dupont, Aurélien Aubry, Jean-Philippe Lanoix, et al.
Journal of the Royal Society, Interface|September 29, 2021
Which features of an outpatient treatment for COVID-19 would be most important for pandemic control? A modelling studyJean-Philippe Lanoix, Youcef Mammeri, Jean-Luc Schmit, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Infectious Diseases Now|December 22, 2025
Knowledge of the French public on antibiotics: where do we stand, twenty years after the celebrated public health campaign "Antibiotics are not Automatic"?Jean-Philippe Lanoix
Advances in Mind-Body Medicine|January 29, 2021
Holistic Medicine Must Mean Whole: How to Deal with SpiritualityJean-Philippe Lanoix, Loren Toussaint
Jac-Antimicrobial Resistance|January 8, 2024
Successful prophylaxis of ESBL Enterobacteriaceae repetitive urinary tract infections with subcutaneous temocillin: a case reportEloïse Delpierre, Jean-Philippe Lanoix
Antimicrobial Agents and Chemotherapy|February 5, 2014
Novel regimens identified in mice for treatment of latent tuberculosis infection in contacts of patients with multidrug-resistant tuberculosisJean-Philippe Lanoix, Fabrice Betoudji, Eric Nuermberger
Antimicrobial Agents and Chemotherapy|December 9, 2015
Sterilizing Activity of Pyrazinamide in Combination with First-Line Drugs in a C3HeB/FeJ Mouse Model of TuberculosisJean-Philippe Lanoix, Fabrice Betoudji, Eric Nuermberger
Current Opinion in Pulmonary Medicine|February 21, 2012
Bacterial lung sepsis in patients with febrile neutropeniaJean-Philippe Lanoix, Jean-Luc Schmit, Youcef Douadi
Disease Models & Mechanisms|June 3, 2015
Heterogeneous disease progression and treatment response in a C3HeB/FeJ mouse model of tuberculosisJean-Philippe Lanoix, Anne J Lenaerts, Eric L Nuermberger
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 4, 2015
Shortening Tuberculosis Treatment With Fluoroquinolones: Lost in Translation?Jean-Philippe Lanoix, Richard E Chaisson, Eric L Nuermberger
Pathogens (Basel, Switzerland)|November 24, 2022
Cytomegalovirus-Associated Gianotti-Crosti Syndrome in 28-Year-Old Immunocompetent PatientFlorence Dupont, Aurélien Aubry, Jean-Philippe Lanoix, et al.
Journal of the Royal Society, Interface|September 29, 2021
Which features of an outpatient treatment for COVID-19 would be most important for pandemic control? A modelling studyJean-Philippe Lanoix, Youcef Mammeri, Jean-Luc Schmit, et al.
Pageof 5